Anna Vanni
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- Immune Cell Function and Interaction
- interferon and immune responses
- T-cell and B-cell Immunology
Papers in
-
- SARS-CoV-2 and COVID-19 Research 9
- COVID-19 Clinical Research Studies 4
- Genetics 2
- Co-authors
- Laura Maggi (12 shared papers)Francesco Annunziato (12 shared papers)Alessio Mazzoni (12 shared papers)Lorenzo Cosmi (11 shared papers)Francesco Liotta (11 shared papers)Manuela Capone (12 shared papers)Lorenzo Salvati (9 shared papers)Alessandro Bartoloni (6 shared papers)
In The Last Decade
Anna Vanni
18 papers receiving 938 citations
Peers
Comparison fields: 5 of 58
- Infectious Diseases 688
- Immunology 138
- General Dentistry 2
- Genetics 24
- Neurology 29
Countries citing papers authored by Anna Vanni
This map shows the geographic impact of Anna Vanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Vanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Vanni more than expected).
Fields of papers citing papers by Anna Vanni
This network shows the impact of papers produced by Anna Vanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Vanni. The network helps show where Anna Vanni may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Vanni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 403 | |
| 2 | 2021 | 111 | |
| 3 | 2021 | 83 | |
| 4 | 2020 | 63 | |
| 5 | 2020 | 60 | |
| 6 | 2020 | 50 | |
| 7 | 2022 | 37 | |
| 8 | 2022 | 31 | |
| 9 | SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies | 2022 | 31 |
| 10 | 2021 | 21 | |
| 11 | 2021 | 18 | |
| 12 | 2020 | 16 | |
| 13 | 2022 | 11 | |
| 14 | 2023 | 10 | |
| 15 | 2023 | 6 | |
| 16 | 2024 | 2 | |
| 17 | 2025 | 2 | |
| 18 | 2023 | 1 | |
| 19 | 2026 | 0 |
About Anna Vanni
Anna Vanni is a scholar working on Infectious Diseases, Genetics, Immunology, Oncology and Biotechnology, having authored 19 papers that have together received 956 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (4 papers), T-cell and B-cell Immunology (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper), Immune cells in cancer (1 paper), Autoimmune and Inflammatory Disorders Research (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Infectious Diseases (688 citations), Immunology (138 citations), General Dentistry (2 citations), Genetics (24 citations) and Neurology (29 citations). Anna Vanni has collaborated with scholars based in Italy, Germany and Denmark. Frequent co-authors include Laura Maggi, Francesco Annunziato, Alessio Mazzoni, Lorenzo Cosmi, Francesco Liotta, Manuela Capone, Lorenzo Salvati, Alessandro Bartoloni, Adriano Peris and Gian María Rossolini. Their work appears in journals such as European Journal of Immunology, Journal of Clinical Investigation, Frontiers in Immunology, PLoS Pathogens and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.